1.53
+0.16(+11.68%)
Currency In USD
Address
26051 Merit Circle
Laguna Hills, DE 92653
United States of America
Phone
949-348-1188
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
80
First IPO Date
July 23, 2024
| Name | Title | Pay | Year Born |
| Mr. Todd Usen | Chief Executive Officer & Director | 448,692 | 1967 |
| Mr. Ilya Grigorov | Vice President of Global Marketing & Product Management | 0 | N/A |
| Mr. Olav B. Bergheim | Advisor | 0 | 1950 |
| Ms. Deborah Kaster | Chief Business Officer | 0 | N/A |
| Mr. Daniel V. George | Interim Chief Financial Officer | 0 | 1970 |
| Mr. Nabil Jubran | Chief Compliance Officer | 0 | N/A |
| Dr. Alex Babkin Ph.D. | Chief Technical Officer | 0 | N/A |
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.